Patent details
EP1677875 Title: A PROTEIN INVOLVED IN OVARIAN CANCER
Basic Information
- Publication number:
- EP1677875
- PCT Application Number:
- PCT/GB/2004/004502
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP047690110
- PCT Publication Number:
- WO/2005/042102
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- A PROTEIN INVOLVED IN OVARIAN CANCER
- French Title of Invention:
- PROTEINE IMPLIQUEE DANS LE CANCER DE L'OVAIRE
- German Title of Invention:
- AN OVARIALKREBS BETEILIGTES PROTEIN
- SPC Number:
Dates
- Filing date:
- 22/10/2004
- Grant date:
- 09/06/2010
- EP Publication Date:
- 09/06/2010
- PCT Publication Date:
- 12/05/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/07/2006
- EP B1 Publication Date:
- 09/06/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 22/10/2010
- Expiration date:
- 22/10/2024
- Renunciation date:
- Revocation date:
- 02/08/2018
- Annulment date:
Owner
- From:
- 22/10/2004
- Name:
- UCB PHARMA, S.A.
- Address:
- ALLÉE DE LA RECHERCHE 60, 1070 BRUSSELS, Belgium (BE)
Inventor
- Name:
- BURGESS Nicola Anne, Celltech R & D Limited
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0324656
- Priority Date:
- 22/10/2003
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 201845
- Publication date:
- 07/11/2018
- Description:
- Revocation of the European patent
| Filing date | Document type | Number of pages |
|---|